George F. Koob, is a Professor and Chair of the Committee on the Neurobiology of Addictive Disorders at The Scripps Research Institute and Adjunct Professor of Psychology

Psychology

Psychology is the study of the mind and behavior. Its immediate goal is to understand individuals and groups by both establishing general principles and researching specific cases. For many, the ultimate goal of psychology is to benefit society...

, Psychiatry

Psychiatry

Psychiatry is the medical specialty devoted to the study and treatment of mental disorders. These mental disorders include various affective, behavioural, cognitive and perceptual abnormalities...

, and Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego

University of California, San Diego

The University of California, San Diego, commonly known as UCSD or UC San Diego, is a public research university located in the La Jolla neighborhood of San Diego, California, United States...

.

Biography

Koob received his Bachelor of Science degree from Pennsylvania State University and his Ph.D. in Behavioral Physiology from The Johns Hopkins University. An authority on addiction and stress, Koob has published over 670 scientific papers and has received continuous funding for his research from the National Institutes of Health, including the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA). He is Director of the NIAAA Alcohol Research Center at The Scripps Research Institute, Consortium Coordinator for NIAAA's multi-center Integrative Neuroscience Initiative on Alcoholism, and Co-Director of the Pearson Center for Alcoholism and Addiction Research. He has trained 10 predoctoral and 64 postdoctoral fellows. Koob is Editor-in-Chief USA for the journal Pharmacology Biochemistry and Behavior and Editor-in-Chief for Journal of Addiction Medicine. He won the Daniel Efron Award for excellence in research from the American College of Neuropsychopharmacology, was honored as a highly cited researcher

ISI highly cited researcher

ISI Highly Cited is a database of "highly cited researchers"—scientific researchers whose publications are most often cited in academic journals over the past decade, published by the Institute for Scientific Information...

 from the Institute for Scientific Information

Institute for Scientific Information

The Institute for Scientific Information was founded by Eugene Garfield in 1960. It was acquired by Thomson Scientific & Healthcare in 1992, became known as Thomson ISI and now is part of the Healthcare & Science business of the multi-billion dollar Thomson Reuters Corporation.ISI offered...

, was presented with the Distinguished Investigator Award from the Research Society on Alcoholism, and won the Mark Keller Award from NIAAA. He published a landmark book in 2006 with his colleague Michel Le Moal entitled: Neurobiology of Addiction (Academic Press-Elsevier, Amsterdam).

His research interests continue to be directed at the neurobiology of emotion, with a focus on the theoretical constructs of reward and stress with a specific interest in understanding the neuroanatomical connections comprising the emotional systems and neurochemistry of emotional function. During the past 3 years, his work has been focused on the role of the extended amygdala (medial shell portion of the nucleus accumbens, bed nucleus of the stria terminalis, and central nucleus of the amygdala) in behavioral responses to stress, the neuroadaptations associated with drug dependence, and compulsive drug self-administration.

Koob’s work on the neurobiology of stress has included the characterization of behavioral functions in the central nervous system for catecholamines, opioid peptides, and corticotropin-releasing factor. Corticotropin-releasing factor, in addition to its classical hormonal functions in the hypothalamic-pituitary-adrenal axis, is also located in extrahypothalamic brain structures and may play an important role in brain emotional function. Recent use of specific corticotropin-releasing factor receptor antagonists suggests that endogenous brain corticotropin-releasing factor may be involved in specific behavioral responses to stress, the psychopathology of anxiety and affective disorders, and drug addiction. He has also characterized functional roles for other stress-related neurotransmitters/neuroregulators, such as norepinephrine, vasopressin, hypocretin (orexin), neuropeptide Y, and neuroactive steroids.

In the domain of drug addiction, Koob’s past work contributed significantly to our understanding of the neurocircuitry associated with the acute reinforcing effects of drugs of abuse. More recently, the focus has been on the neuroadaptations of these reward circuits and the recruitment of the brain stress systems during with the transition to dependence. To this end, he has validated key animal models for dependence associated with drugs of abuse and has begun to explore a key role of anti-reward systems in the development of dependence. The neurotransmitter systems in the extended amygdala under current investigation include corticotropin-releasing factor, norepinephrine, dynorphin, orexin, neuropeptide Y, and the sigma receptor system.

The identification of specific neurochemical systems within the basal forebrain system of the extended amygdala involved in motivation has significant theoretical and heuristic impacts. From a theoretical perspective, identification of a role for dopaminergic, opioidergic, γ-aminobutyric acid, glutamatergic, and corticotropin-releasing factor systems in excessive drug taking provides a neuropharmacologic basis for the allostatic changes hypothesized to drive the process of pathology associated with addiction, anxiety, and depression. From a heuristic perspective, these findings provide a framework for further molecular, cellular, and neurocircuitry research that will identify the basis for individual differences in vulnerability to pathology.

Finally, Koob’s recent contributions include scholarly treatises on the conceptual framework and theoretical bases for understanding the neurobiology of drug addiction. He has contributed key reviews on the “dark side of addiction” in very prominent journals in the field, including Annual Review of Psychology, Nature, Neuron, and Neuropsychopharmacology, and Nature Reviews Drug Discovery.

Professional training and positions

2006–present	Professor and Chair, Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute.
1995–Present	Director, Alcohol Research Center, The Scripps Research Institute.
1990-2006	Professor, Molecular and Integrative Neurosciences Department (formerly the Department of Neuropharmacology), The Scripps Research Institute.
1983-1989	Associate Member (with tenure), Division of Preclinical Neuroscience and Endocrinology, The Scripps Research Institute.
1983-1989	Associate Member (with tenure), Division of Preclinical Neuroscience and Endocrinology, The Scripps Research Institute.
1977-1983	Staff Scientist, Arthur Vining Davis Center for Behavioral Neurobiology, The Salk Institute for Biological Studies.
1975-1977	Postdoctoral Fellow with Susan D. Iversen, University of Cambridge, Department of Experimental Psychology, Medical Research Council, Neurochemical Pharmacology Unit. Studies in: catecholamines and behavior.
1972-1975	Staff Scientist, Department of Neurophysiology, Walter Reed Army Institute of Research. Studies in: brain lesions, brain stimulation, behavior, neurochemistry, psychopharmacology.
1969-1972	Predoctoral Fellow, Johns Hopkins University, Department of Environmental Medicine. Training in: physiology, behavior, neurochemistry, environmental physiology.
1965-1969	Undergraduate, Pennsylvania State University, Training in: zoology and psychology.

University Affiliation:

2006–present	Adjunct Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego.
1989–present	Adjunct Professor, Departments of Psychology and Psychiatry, University of California, San Diego.
1983-1989	Associate Adjunct Professor, Department of Psychology, University of California, San Diego.
1987-1989	Associate Adjunct Professor, Department of Psychiatry, University of California, San Diego.
1980-1983	Assistant Adjunct Professor, Department of Psychology, University of California, San Diego.

Journal Editor:

• Pharmacology Biochemistry and Behavior (Editor-in-Chief, 1994–present)
• Journal of Addiction Medicine (Senior Editor, 2007–present)
• Brain Research (Section Editor, 2008–present; Special Issue Guest Editor, Biomedical Alcohol Research, 2009, vol. 1305S)

Awards:

• Phi Sigma Society
• Alpha Zeta Fraternity
• Outstanding Faculty Teaching Award, Revelle College, University of California, San Diego (1988)
• Outstanding Faculty Teaching Award, Muir College, University of California, San Diego (1989)
• Outstanding Faculty Teaching Award, Warren College, University of California, San Diego (1992, 1993, 1995)
• Daniel H. Efron Award, Excellence in Research in Neuropsychopharmacology, American College of Neuropsychopharmacology (1991)
• Highly Cited Researcher, Institute for Scientific Information (2001)
• Distinguished Investigator Award, Research Society on Alcoholism (2002)
• ASAM Annual Award, American Society of Addiction Medicine
  American Society of Addiction Medicine
  The American Society of Addiction Medicine is a physician society with a focus on addiction and its treatment.- History :ASAM has its roots in research and clinical traditions that pre-date its founding in the early 1950s, when Ruth Fox, M.D. began regular meetings with other physicians interested...
  
  (2002)
• Tharp Award, James H. Tharp Trust Committee, Research Society on Alcoholism (2002)
• Most Valuable Professor, Muir College, University of California, San Diego (2004)
• Mark Keller Award, National Institute on Alcohol Abuse and Alcoholism (2004)
• Faculty Excellence Award, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego (2006)
• Honorary Doctorate of Science, Pennsylvania State University (2009)
• Outstanding UCSD Professor Award, Panhellenic Council, University of California, San Diego (2010)

Lectureships:

• Commencement Speaker, Warren College, University of California, San Diego (1993)
• Boots Distinguished Neuroscientist, Louisiana State University Medical Center (1989)
• Grass Foundation Lecturer, Society for Neuroscience, Indianapolis Chapter (1990)
• Grass Foundation Lecturer, Society for Neuroscience, Central New York Chapter (1990)
• Grass Foundation Lecturer, Society for Neuroscience, South Carolina Chapter (1992)
• Grass Foundation Lecturer, Society for Neuroscience, West Virginia Chapter (1993)
• Grass Foundation Lecturer, Society for Neuroscience, Northern Rocky Mountain Chapter (1994)
• John C. Forbes Honors Lectureship, School of Basic Health Sciences, Virginia Commonwealth University (1991)
• Wendy and Stanley Marsh Endowed Lectureship, Texas Tech University Health Sciences Center, Amarillo (1999)
• Bowles Lectureship, Center for Alcohol Studies, University of North Carolina (2000)
• Jellinek Lectureship, Substance Abuse Treatment Unit, Yale University School of Medicine (2000)
• Mark Nickerson Memorial Lecture Award, Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada (2006)
• Paul Stark Lecture, Department of Pharmacology and Physiology, University of Rochester Medical Center (2008)
• Louis S. Harris Sterling Drug Visiting Professor, Virginia Commonwealth University (2009).
• Lyon-Voorhees Lectureship, University of Colorado Denver (2010).
• Norman E. Zinberg Memorial Lecture, Department of Psychiatry, Division on Addictions, Cambridge Health Alliance, Harvard Medical School (2010).